Essex Bio-Technology Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was HKD 737.374 million compared to HKD 323.835 million a year ago. Net income was HKD 162.186 million compared to HKD 49.188 million a year ago. Basic earnings per share from continuing operations was 28.12 HK cents compared to 8.51 HK cents a year ago. Diluted earnings per share from continuing operations was 27.38 HK cents compared to 8.51 HK cents a year ago.